Letter by Lin et al regarding article, "Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention"

Circulation. 2010 Feb 23;121(7):e43; author reply e44-5. doi: 10.1161/CIR.0b013e3181d2e8b2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abciximab
  • Angioplasty, Balloon, Coronary*
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / drug therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Abciximab